ATE230591T1 - Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie - Google Patents

Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie

Info

Publication number
ATE230591T1
ATE230591T1 AT98946538T AT98946538T ATE230591T1 AT E230591 T1 ATE230591 T1 AT E230591T1 AT 98946538 T AT98946538 T AT 98946538T AT 98946538 T AT98946538 T AT 98946538T AT E230591 T1 ATE230591 T1 AT E230591T1
Authority
AT
Austria
Prior art keywords
cosmetics
derivatives
dermatology
ellagic acid
relates
Prior art date
Application number
AT98946538T
Other languages
English (en)
Inventor
Frederic Bonte
Alex Saunois
Original Assignee
Lvmh Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvmh Rech filed Critical Lvmh Rech
Application granted granted Critical
Publication of ATE230591T1 publication Critical patent/ATE230591T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98946538T 1997-10-01 1998-10-01 Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie ATE230591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9712227A FR2768927B1 (fr) 1997-10-01 1997-10-01 Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
PCT/FR1998/002098 WO1999016415A1 (fr) 1997-10-01 1998-10-01 Utilisation de l'acide ellagique et de ses derives en cosmetique et en dermatologie

Publications (1)

Publication Number Publication Date
ATE230591T1 true ATE230591T1 (de) 2003-01-15

Family

ID=9511692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946538T ATE230591T1 (de) 1997-10-01 1998-10-01 Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie

Country Status (8)

Country Link
US (1) US20020098213A1 (de)
EP (1) EP1021161B1 (de)
JP (1) JP5010775B2 (de)
AT (1) ATE230591T1 (de)
DE (1) DE69810649T2 (de)
ES (1) ES2190606T3 (de)
FR (1) FR2768927B1 (de)
WO (1) WO1999016415A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6471972B1 (en) * 1996-11-07 2002-10-29 Lvmh Recherche Cosmetic treatment method for fighting against skin ageing effects
JP4213836B2 (ja) * 2000-02-09 2009-01-21 株式会社マンダム 育毛剤組成物
JP4213837B2 (ja) * 2000-02-18 2009-01-21 株式会社マンダム 育毛剤組成物
FR2809004B1 (fr) * 2000-05-18 2002-12-27 Oreal Utilisation de l'acide ellagique comme agent cosmetique anti-pollution
FR2812873B1 (fr) * 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
US20050238730A1 (en) * 2001-11-21 2005-10-27 Agnes Le Fur Compositions comprising an ethanolamine derivative and organic metal salts
EP1348421A3 (de) * 2002-03-25 2004-01-02 L'oreal Verfahren zur Verdichtung und Formung von menschlichen Keratinfasern unter Verwendung eines bestimmten Katalysatorsystems
FR2847805B1 (fr) * 2002-11-28 2005-01-07 Oreal Procede de densification des fibres keratiniques humaines utilisant un systeme catalytique particulier
EP1398019A1 (de) * 2002-09-13 2004-03-17 Cognis France S.A. Verfahren zum Schutz und zur Modulation von Dermal Epidermal Junctions
JP2004137166A (ja) * 2002-10-16 2004-05-13 Noevir Co Ltd 皮膚外用剤、細胞賦活剤、抗酸化剤
FR2848117B1 (fr) * 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
JP5420136B2 (ja) * 2005-03-11 2014-02-19 サントリーホールディングス株式会社 抗老化剤
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
CA2603102C (en) * 2005-03-29 2015-08-11 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
WO2006137129A1 (ja) * 2005-06-21 2006-12-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 皮膚外用剤
KR101324578B1 (ko) * 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
FR2902324B1 (fr) * 2006-06-20 2009-04-03 Oreal Utilisation d'acide ellagique pour le traitement de la canitie
GB0801119D0 (en) * 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
DE102008008540A1 (de) * 2008-02-07 2009-08-13 Beiersdorf Ag Hautpflegezubereitung zur Pflege von gestresster Haut
KR101068763B1 (ko) 2009-02-05 2011-09-28 한림대학교 산학협력단 엘라직산을 함유하는 자외선에 의한 피부노화 억제용 조성물
DE102009002227A1 (de) * 2009-04-06 2010-10-07 Henkel Ag & Co. Kgaa Hautbehandlungsmittel gegen Hautalterung I
DE102009002226A1 (de) * 2009-04-06 2010-10-07 Henkel Ag & Co. Kgaa Hautbehandlungsmittel gegen Hautalterung II
DE102009027024A1 (de) * 2009-06-18 2010-12-23 Henkel Ag & Co. Kgaa Antifalten-Kosmetikum mit Antioxidantien
FR2956812B1 (fr) * 2010-03-01 2013-03-08 Oreal Composition cosmetique a base d'acide ellagique ou d'un de ses derives et d'un extrait de bacterie.
FR2956811B1 (fr) * 2010-03-01 2012-05-25 Oreal Composition cosmetique anti-pelliculaire a base d'acide ellagique ou d'un de ses derives et d'un second compose actif different dans un rapport ponderal particulier.
FR2956808B1 (fr) * 2010-03-01 2012-05-25 Oreal Utilisation de l'acide ellagique comme agent anti-pelliculaire.
FR2967061B1 (fr) * 2010-11-09 2013-06-14 Oreal Utilisation d'extrait de grenade pour prevenir et/ou traiter des symptomes lies aux cheveux ages
US8895034B2 (en) 2011-11-02 2014-11-25 Mark K Bennett Collagen production compound
WO2015023926A1 (en) 2013-08-15 2015-02-19 Mary Kay Inc. Topical skin compositions for treating wrinkles
DE102014111357B4 (de) 2014-08-08 2018-09-27 Minasolve Germany Gmbh Ellagsäure enthaltende Partikel und Verfahren zu ihrer Herstellung
FR3032611B1 (fr) * 2015-02-13 2017-02-24 Oreal Utilisation de l'acide ellagique pour matifier la peau
KR101701217B1 (ko) * 2015-09-30 2017-02-01 연세대학교 산학협력단 밤송이로부터 추출된 물질을 함유하는 탈모 예방 또는 치료용 약학 조성물
KR101926331B1 (ko) * 2016-04-12 2018-12-07 (주)안트로젠 수포성 표피박리증 완화 또는 개선용 중간엽줄기세포-하이드로겔-생분해성 또는 중간엽줄기세포-하이드로겔-비분해성 지지체 조성물
ES2985944T3 (es) * 2016-06-29 2024-11-07 Halo Life Science Llc Método de preparación de una sal de ellagato de dicolinio de poco olor y otras sales orgánicas de colina de poco olor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366836A1 (fr) * 1976-10-08 1978-05-05 Cariel Leon Nouveau produit pour le traitement curatif et preventif du tissu conjonctif
JPS6015486A (ja) * 1983-07-07 1985-01-26 M S C:Kk 抗酸化剤
FR2611140B1 (fr) * 1987-02-20 1991-02-22 Lamaison Jean Louis Procede d'obtention de principes tanniques d'origine vegetale, composition cosmetologique et composition pharmaceutique contenant le principe tannique purifie obtenu selon le procede
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
JPH02269176A (ja) * 1988-12-09 1990-11-02 Lion Corp 紫外線吸収剤及びこれを配合した化粧料
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
JP2804283B2 (ja) * 1989-03-06 1998-09-24 ライオン株式会社 皮膚用外用剤
JP2786232B2 (ja) * 1989-03-06 1998-08-13 ライオン株式会社 新規な皮膚外用剤
JP2780805B2 (ja) * 1989-03-06 1998-07-30 ライオン株式会社 新規な皮膚外用剤組成物
FR2671723B1 (fr) * 1991-01-22 1995-01-13 Synthelabo Extraits de noix d'alep, leur preparation et leurs applications.
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
FR2715582B1 (fr) * 1994-02-02 1996-03-15 Centre Nat Rech Scient Microcapsules à paroi de flavonoïde réticulée et compositions en contenant.
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
US5529769A (en) * 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US6004568A (en) * 1995-02-17 1999-12-21 Lvmh Recherche Cosmetic or pharmaceutical, particularly dermatological, composition containing a Bertholletia extract
FR2730635B1 (fr) * 1995-02-17 1997-05-09 Lvmh Rech Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de bertholletia
FR2737971B1 (fr) * 1995-08-25 1997-11-14 Lvmh Rech Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
FR2742987B1 (fr) * 1996-01-03 1998-04-03 Lvmh Rech Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes

Also Published As

Publication number Publication date
DE69810649D1 (de) 2003-02-13
JP2001517688A (ja) 2001-10-09
US20020098213A1 (en) 2002-07-25
DE69810649T2 (de) 2003-09-25
FR2768927B1 (fr) 2000-01-21
ES2190606T3 (es) 2003-08-01
JP5010775B2 (ja) 2012-08-29
EP1021161A1 (de) 2000-07-26
FR2768927A1 (fr) 1999-04-02
HK1031684A1 (en) 2001-06-22
WO1999016415A1 (fr) 1999-04-08
EP1021161B1 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
ATE230591T1 (de) Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie
DE69902131D1 (de) Kosmetische und/oder dermatologische Zusammensetzung enthaltend Salicylsäure oder ihre Derivate und ihre Verwendung
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
DE69813935D1 (de) Verwendung von Retinoiden zur Induzierung von Hautpigmentierung
DE59913204D1 (de) Verwendung von Nanodispersionen in kosmetischen Endformulierungen
ATE304838T1 (de) Kombination von erythrulose und einem reduzierenden zucker mit selbstbräunungseigenschaften
ATE336222T1 (de) Kosmetische zusammensetzung enthaltend einen photochromen farbstoff, deren verwendung als make-up und/oder zur pflege der haut und/oder der hautanhangsgebilde
DE69716251D1 (de) Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne
DE4393944T1 (de) Verwendung von Ecdysteroiden in der Kosmetik und Dermatologie
DE60140477D1 (de) Kosmetische zusammensetzung mit einer kontinuierlichen lipophilen phase, die fasern enthält
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
DE59407737D1 (de) Verwendung von alkandiolen in kosmetischen produkten
DE69807454D1 (de) Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden
DE69503179D1 (de) Kosmetische und/oder dermatologische Zusammensetzung, die ein Tri (alpha-hydroxyacylat) von glycerin als einzigen Glycerinprecursor enthält
DE69840253D1 (de) Verwendung von Inhibitoren exzitatorischer Aminosäuren in kosmetischen oder dermatologischen Zubereitungen für empfindliche Haut sowie Zubereitung
WO1998019664A3 (fr) Utilisation d'un extrait de potentilla erecta dans le domaine de la cosmetique et de la pharmacie
DE69821685D1 (de) Ethanolische Lösungen von N-Pentadecanoylisoleucin und Verwendung derselben in der Kosmetik
ATE211905T1 (de) Verwendung von mindestens einen chrysanthemum gattungs extrakten zur förderung der haut- und/oder der haarepigmentierung
DE69400727D1 (de) Verwendung von 4-Thiuoresorcin-Derivaten in kosmetischen oder dermopharmazeutischen Zusammensetzungen zur Hautdepigmentierung
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
DE69704197D1 (de) Verwendung von Citronensäureestern zur Verbesserung der Auswaschbarkeit ölhaltiger kosmetischer Zusammensetzungen
ATE521331T1 (de) Verwendung von bis-resorcinyltriazinderivaten in kosmetischen oder dermatologischen zubereitungen
DE60044633D1 (de) Nicht therapeutische Verwendung von N-acetylglucosamin zur Hautschälung
BRPI0413992A (pt) processo de redução de irritação em composições de cuidados pessoais
ATE228350T1 (de) Verwendung eines terminalia catappa extraktes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties